← Back to Search

Other

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

Phase 2
Waitlist Available
Research Sponsored by Novartis Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 169

Summary

This trial is testing a new treatment called MBL949 to help people who are overweight or have Type 2 Diabetes. The study includes a period to check participants' health, followed by several weeks of treatment and a follow-up. MBL949 aims to help manage weight and blood sugar levels better than current treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 169
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to day 169 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change-from-baseline in Weight
Frequency and Severity of Adverse Events

Trial Design

6Treatment groups
Active Control
Placebo Group
Group I: MBL949 Arm 4Active Control1 Intervention
MBL949 one 1.5 mg dose followed by seven doses of 2.2 mg
Group II: MBL949 Arm 1Active Control1 Intervention
MBL949 one 3 mg dose followed by two doses of 6 mg followed by five doses of 4.5 mg
Group III: MBL949 Arm 5Active Control1 Intervention
MBL949 one 3 mg dose followed by two doses of 6 mg followed by five doses of 7.5 mg
Group IV: MBL949 Arm 2Active Control1 Intervention
MBL949 two 3 mg doses followed by six doses of 4.5 mg
Group V: MBL949 Arm 3Active Control1 Intervention
MBL949 one 12 mg dose followed by seven doses of 4.5 mg
Group VI: PlaceboPlacebo Group1 Intervention
Placebo to MBL949

Find a Location

Who is running the clinical trial?

Novartis PharmaceuticalsLead Sponsor
2,916 Previous Clinical Trials
4,253,759 Total Patients Enrolled
6 Trials studying Obesity
793 Patients Enrolled for Obesity
~33 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top